IN8bio, Inc. Reports Board and Officer Changes
Ticker: INAB · Form: 8-K · Filed: Mar 5, 2025 · CIK: 1740279
| Field | Detail |
|---|---|
| Company | In8bio, Inc. (INAB) |
| Form Type | 8-K |
| Filed Date | Mar 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, management-change, personnel
TL;DR
IN8BIO reshuffled its board and execs, new comp plans in play.
AI Summary
On March 4, 2025, IN8bio, Inc. filed an 8-K report detailing changes in its board of directors and executive officers. The filing indicates the election of new directors and the appointment of certain officers, along with updates to compensatory arrangements for these individuals. This report signifies internal governance adjustments within the company.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategic direction or operational focus, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- IN8BIO, INC. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- March 4, 2025 (date) — Date of earliest event reported
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of new directors, but the specific names and their backgrounds are not detailed in this summary section of the 8-K.
Were there any changes to the executive officer positions?
Yes, the filing mentions the appointment of certain officers, suggesting potential changes in executive roles.
What is the nature of the updates to compensatory arrangements?
The filing states there are updates to compensatory arrangements for certain officers, but the specifics of these arrangements are not provided in this section.
When did these reported changes take effect?
The earliest event reported in this filing occurred on March 4, 2025.
What is IN8bio, Inc.'s primary business?
IN8bio, Inc. is in the business of Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 5, 2025 regarding IN8BIO, INC. (INAB).